Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02153736 · ClinicalTrials.gov registry record · NA

Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT02153736: Completed NA study, sponsored by Virginia Commonwealth University.

NCT02153736 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02153736, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

The primary aims of this randomized controlled trial are to evaluate efficacy potential of SPEEDI at enhancing reaching and play based problem solving compared to infants receiving usual care.

Primary Outcome

Duration the infant is in contact with the target is used to quantify changes in reaching.

Interventions

  • BEHAVIORAL SPEEDI Intervention

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2014-04
Est. Completion 2016-10
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT02153736 record still lists

NCT02153736 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which SPEEDI Intervention is the first listed.

NCT02153736 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02153736 about?

NCT02153736 is a clinical study titled "Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention". The primary aims of this randomized controlled trial are to evaluate efficacy potential of SPEEDI at enhancing reaching and play based problem solving compared to infants receiving usual care.

What is the current status of trial NCT02153736?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2014-04. Estimated completion is 2016-10.

What interventions are being tested in trial NCT02153736?

The interventions under investigation include: SPEEDI Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02153736?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02153736's enrollment target sits among peer trials

14 1909th of 2000 higher than 90 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02153736, the US trial registry maintained by the National Library of Medicine. NCT02153736 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.